Biomarkers for Noninvasive Assessment of Human Hydration

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-10-31

Study Completion Date

2012-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low levels of dehydration (the loss of body water corresponding to 2% of the body weight), deteriorate physical and cognitive performance and may also be linked to a number of chronic diseases. The standard test used for the assessment of hydration status is plasma osmolality. This blood test is invasive, requires time and laboratory equipment and is not accurate for isotonic dehydration. The goal of this project is to determine whether a new molecular technology, saliva-based Stress Response Profiling (SRP) biomarkers, could be used for non-invasive diagnostics of dehydration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dehydration, or the loss of body water, is a common health problem during military operations, athletic events and illness, particularly in children and the elderly. Warfighters frequently become dehydrated when training or fighting in hot and mountainous environments because heat and high altitude increase body water losses. The negative consequences of dehydration worsen as body water losses increase. Severe dehydration (\>10%) is a life-threatening emergency that may result in heat illness, seizures, permanent brain damage or death. The most common type of dehydration is caused by sweat loss during heavy physical labor or exercise (hypertonic dehydration). A different type of dehydration can be caused by blood loss, burns, diarrhea, vomiting or diuretic drugs used for example by diabetics (isotonic dehydration). Despite the critical importance of proper fluid balance to human performance and health, no field-expedient, non-invasive dehydration test is available for either form of dehydration. The ultimate goal of this project is to develop a field-expedient, non-invasive test for both types of dehydration. The test will be sensitive to 2% dehydration, a critical threshold for performance impairment and a statistically valid decision point for hydration assessment.

Design: Fifteen volunteers will be first euhydrated (well-hydrated) and then moderately dehydrated (2-4%) using two procedures. First, sweat loss during exercise in the heat without fluids (hypertonic dehydration). Second, excessive urination stimulated by a diuretic pill called Lasix (isotonic dehydration). SRP biomarkers in saliva samples will be compared to changes in body weight, and to known hydration indicators in blood and urine. Results will identify the best SRP biomarkers for diagnosing both types of dehydration and compare accuracy of the new saliva test to the existing hydration indicators.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dehydration

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

dehydration plasma osmolality saliva urine biomarkers hypertonic isotonic hydration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed Informed Consent Form
* Males and females between 18-40, healthy and aerobically fit determined by VO2max test. Minimum 45 ml/kg/min for males and 40 ml/kg/min for females
* Willing to stop drinking any alcoholic beverages, taking all supplements and limit medications to those approved for the study
* No heart conditions assessed by medical history and passing the PAR-Q
* Complete and pass medical exam

Exclusion Criteria

* Positive response to any PAR-Q questions
* Physical problems/injuries associated with walking or cycling
* VO2Max below 45 ml/kg/min for men and 40 ml/kg/min for women
* Allergy to sulfa drugs
* Existing heart and or lung conditions
* Pregnant or breastfeeding
* History of heat illness or heat injury
* History of kidney stones or chronic renal problems
* History of orthostatic hypotension, diabetes or gout
* Taking certain medications: NSAIDS \[anti-inflammatory/pain medications\], digitalis \[a type of heart medication\], lithium and anti-depressants \[medications used in psychiatry\], anti-hypertensives \[medications to lower the blood pressure\], anti-fungals \[medications used to treat infectious type of mold\], supplements or anti-cholinergic drugs)
* Taking any supplements, particularly creatine in 24 hours before the start of the study, or during the study
* Alcohol consumption 24 hours before the start of the study, or during the study
* Incapable to give informed consent
* Anemia

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter D Wagner, M.D.

Role: PRINCIPAL_INVESTIGATOR

University of California, San Diego

Sarka Southern, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Gaia Medical Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical and Translational Research Institute

San Diego, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DM102745

Identifier Type: -

Identifier Source: org_study_id